---
title: "Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issued"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293443950.md"
description: "Pharmaron Beijing filed a next-day disclosure with the HKEX on July 22, reporting the issuance of 5,396,470 new H shares moved from treasury to a trustee. Consequently, issued H shares excluding treasury increased by 1.53% to 358,111,057, while treasury shares decreased to 1,866,830. The total number of shares remained unchanged at 359,977,887."
datetime: "2026-07-22T08:40:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293443950.md)
  - [en](https://longbridge.com/en/news/293443950.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293443950.md)
generator: "portal-rs"
---

# Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issued

-   Pharmaron Beijing filed a next-day disclosure return showing 5,396,470 H shares moved from treasury to a trustee on July 22. \* Issued H shares excluding treasury rose 1.53% to 358,111,057; treasury shares fell to 1,866,830; total shares stayed 359,977,887. \* Total new or converted shares: 0. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260722-12252336), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)

## Related News & Research

- [Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 Results](https://longbridge.com/en/news/292495648.md)
- [3 Next-Gen AI Stocks That 3G Capital Bought in Q2](https://longbridge.com/en/news/296496173.md)
- [88% of Nvidia's portfolio is invested in these 3 artificial intelligence (AI) stocks](https://longbridge.com/en/news/296341788.md)
- [Glory Health sets board meeting to review interim results, dividend recommendation](https://longbridge.com/en/news/296347543.md)
- [Ascentage Pharma posts interim results presentation on 1H 2026 business update](https://longbridge.com/en/news/296418315.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**